细胞损伤的临床试验
总计33887个结果
-
University of California, Los AngelesCenters for Disease Control and Prevention完全的免疫状态 | Well 托儿所参观
-
AstraZeneca主动,不招人第 1 部分:晚期 B 细胞恶性肿瘤 | 第 2 部分:r/rCLL 和 r/rMCL | 第 3 部分:未经治疗的 CLL日本
-
Norwegian School of Sport SciencesUniversity of Oslo; Oslo University Hospital; University of Copenhagen; Université de Nantes; Syddansk...完全的
-
CellSight Technologies, Inc.Oregon Health and Science University; Stanford University招聘中
-
Piramal Enterprises LimitedDana-Farber Cancer Institute; Norris Cotton Cancer Center暂停
-
Hackensack Meridian HealthCelgene Corporation终止
-
AstraZenecaCLL Consortium完全的
-
University of California, IrvineUnited States Department of Defense主动,不招人
-
CRISPR Therapeutics AG招聘中滤泡性淋巴瘤 | B细胞淋巴瘤 | 套细胞淋巴瘤 | 边缘区淋巴瘤 | 非霍奇金淋巴瘤 | B细胞恶性肿瘤 | 大 B 细胞淋巴瘤 | 慢性淋巴细胞白血病 (CLL)/小淋巴细胞淋巴瘤 (SLL)美国
-
Gruppo Italiano Malattie EMatologiche dell'Adulto未知
-
Alexion PharmaceuticalsPortola Pharmaceuticals完全的滤泡性淋巴瘤(FL/惰性 NHL) | 侵略性 NHL(一种 NHL) | 慢性淋巴细胞白血病 (CLL) / 小淋巴细胞淋巴瘤 (SLL) | T 细胞淋巴瘤(PTCL 和 CTCL) | B 细胞非霍奇金淋巴瘤 (NHL)美国
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy, Baylor College...主动,不招人
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis Pharmaceuticals完全的套细胞淋巴瘤 | 灰区淋巴瘤 | 霍奇金病 | CD20+、B 细胞淋巴瘤 | 非套细胞低级别 B 细胞淋巴瘤 (SLL/CLL) | 转化淋巴瘤/DLBCL/PMBCL美国
-
Gilead Sciences完全的淋巴瘤,滤泡性 | 淋巴瘤,B细胞 | 淋巴瘤,非霍奇金 | 淋巴瘤,低级别 | 淋巴瘤,小淋巴细胞 | 白血病,幼淋巴细胞 | 非霍奇金淋巴瘤 | 慢性淋巴细胞白血病 | 白血病,淋巴细胞性,慢性 | 淋巴瘤,中级 | 淋巴瘤,大细胞 | 淋巴瘤,混合细胞 | 淋巴瘤,小细胞 | 白血病,B细胞,慢性 | 白血病,小淋巴细胞 | 淋巴瘤、淋巴浆细胞样细胞、CLL | 淋巴浆细胞样淋巴瘤,CLL | SLL美国
-
Steven E. CoutreBayer完全的
-
University of ZagrebUniversity of Split, School of Medicine招聘中
-
VIST - Faculty of Applied SciencesEuropean Regional Development Fund; Slovenian Research Agency; Ministry of Education, Science...完全的
-
Federal University of Health Science of Porto Alegre完全的
-
Bispebjerg HospitalSygehus Lillebaelt主动,不招人
-
French Innovative Leukemia OrganisationRoche Pharma AG完全的
-
R.J.H. CustersZonMw: The Netherlands Organisation for Health Research and Development招聘中
-
Universidad San Francisco de QuitoBiomolec Pharma完全的
-
Hackensack Meridian HealthCelgene Corporation完全的
-
University of California, San DiegoCelgene Corporation撤销
-
Tampere University HospitalTurku University Hospital; Finnish Institute for Health and Welfare完全的
-
French Innovative Leukemia Organisation终止